November 22, 2024
Vetter names three co-managing directors
Vetter, globally operating Contract Development and Manufacturing Organization (CDMO), has appointted three senior leaders to take on the role of…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
November 22, 2024
BioAdaptives, Inc. Announces 5 Unique Products Ready for Phased Entry Into the Nutritional Marketplace
LAS VEGAS, Nov. 21, 2024 (GLOBE NEWSWIRE) — BioAdaptives Inc. (OTC: BDPT) ushered in a new direction by appointing James…
November 22, 2024
Notice of AGM
DXS INTERNATIONAL PLC (AQSE: DXSP) Notice of 2024 Annual General Meeting The Board of DXS International plc (“the Company” or…
November 22, 2024
BioXcel Therapeutics Announces Proposed Public Offering
NEW HAVEN, Conn., Nov. 21, 2024 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing…
November 22, 2024
High Haven Celebrates “Danksgiving” Cannabis Event with Green Wednesday and Holiday Deals Across Illinois Locations
WOODRIDGE, Ill., Nov. 21, 2024 (GLOBE NEWSWIRE) — High Haven Dispensary, recognized as Illinois’ top-rated cannabis retailer, invites cannabis enthusiasts…
November 22, 2024
BioAge Labs to Present at Upcoming Investor Conferences
RICHMOND, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) — BioAge Labs (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biopharmaceutical company developing…
November 22, 2024
Kane Biotech to Release Third Quarter 2024 Financial Results on November 28, 2024
Conference Call to be held on December 3, 2024WINNIPEG, Manitoba, Nov. 21, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-…
November 22, 2024
Lifecore Biomedical Hosts Virtual Investor Day
CHASKA, Minn., Nov. 21, 2024 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and…
November 22, 2024
Replimune Receives Breakthrough Therapy Designation for RP1 and Submits RP1 Biologics License Application to the FDA under the Accelerated Approval Pathway
WOBURN, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the…
November 22, 2024
Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
Attributes 2,440% revenue growth to increased adoption of its Proteograph™ Product Suite and exciting discoveries made by Seer customers across…